Baseline brain MRI results showed that 14% of 101 patients had asymptomatic brain lesions, with higher rates in patients with triple-negative (TNBC) and HER2-positive versus hormone receptor (HR ...

15% in HER2-positive breast cancer; ... More information: Kamran A Ahmed et al, Phase II Trial of Brain MRI Surveillance in Stage IV Breast Cancer, Neuro-Oncology (2025).

These patients underwent MRI scans to check for brain metastasis, with a follow-up MRI six months later if the initial scan showed no signs of cancer spread. Of the patients who completed the ...

In the last few years there has been tremendous progress in the treatment of metastatic HER2-positive breast cancer. "We are getting a lot of therapeutic options coming into this space," said ...

Trastuzumab deruxtecan (Enhertu, T-DXd) therapy produced "substantial and durable" overall and intracranial clinical activity in patients with HER2-positive advanced breast cancer, according to ...

HER2 is a protein that’s on the outside of all breast cells, whether they’re normal or cancerous. But when your breast cancer is described as HER2-positive, it means the cancer cells have more ...

In animal studies led by researchers at Duke Cancer Institute, a drug approved to treat leukemia successfully disrupted the ability of HER2-positive breast cancer tumors from colonizing the brain.

Whether you have HER2-positive breast cancer, HER2-negative, or something else entirely, the type of cancer you have will determine your treatment & prognosis.

Study supports routine brain MRI screening in asymptomatic late-stage breast cancer patients. ... Systemic treatment for brain metastasis in HER2-positive advanced breast cancer. Sep 13, 2023.

Routine brain MRI screening in asymptomatic late stage breast cancer patients New study shows brain metastasis is more common than previously thought, ... 15% in HER2-positive breast cancer; ...